A prescription for change: the looming crisis in drug development
Saved in:
| Main Author: | |
|---|---|
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Chapel Hill
The University of North Carolina Press
2016
|
| Series: | Luther H. Hodges, Jr. and Luther H. Hodges, Sr. series on business, entrepreneurship, and public policy
|
| Subjects: | |
| Online Access: | FLA01 |
| Item Description: | Print version record |
| Physical Description: | 1 online resource (xi, 339 pages) |
| ISBN: | 1469630648 9781469630649 |
Staff View
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV045360089 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 181212s2016 |||| o||u| ||||||eng d | ||
| 020 | |a 1469630648 |9 1-4696-3064-8 | ||
| 020 | |a 9781469630649 |9 978-1-4696-3064-9 | ||
| 035 | |a (ZDB-4-EBU)ocn959609251 | ||
| 035 | |a (OCoLC)959609251 | ||
| 035 | |a (DE-599)BVBBV045360089 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 615.1/9 |2 23 | |
| 100 | 1 | |a Kinch, Michael S. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a A prescription for change |b the looming crisis in drug development |c Michael S. Kinch |
| 264 | 1 | |a Chapel Hill |b The University of North Carolina Press |c 2016 | |
| 300 | |a 1 online resource (xi, 339 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Luther H. Hodges, Jr. and Luther H. Hodges, Sr. series on business, entrepreneurship, and public policy | |
| 500 | |a Print version record | ||
| 505 | 8 | |a The introduction of new medicines has dramatically improved the quantity and quality of individual and public health while contributing trillions of dollars to the global economy. In spite of these past successes -- and indeed because of them -- our ability to deliver new medicines may be quickly coming to an end. Moving from the beginning of the twentieth century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy. To explain how we have arrived at this pivotal moment, Michael Kinch recounts the history of pharmaceutical and biotechnological advances in the twentieth century. Kinch relates stories of the individuals and organizations that built the modern infrastructure that supports the development of innovative new medicines. He shows that an accelerating cycle of acquisition and downsizing is cannibalizing that infrastructure Kinch demonstrates the dismantling of the pharmaceutical and biotechnological research and development enterprises could also provide opportunities to innovate new models that sustain and expand the introduction of newer and better breakthrough medicines in the years to come. - Publisher | |
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 7 | |a BUSINESS & ECONOMICS / Development / Business Development |2 bisacsh | |
| 650 | 7 | |a Drug development |2 fast | |
| 650 | 7 | |a Drugs / Research / Economic aspects |2 fast | |
| 650 | 7 | |a Pharmaceutical industry |2 fast | |
| 650 | 4 | |a Drug Design | |
| 650 | 4 | |a Drug development |a Drugs |x Research |x Economic aspects |a Pharmaceutical industry | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Kinch, Michael S. |t Prescription for change |d Chapel Hill : University of North Carolina Press, [2016] |z 9781469630625 |
| 912 | |a ZDB-4-EBU | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030746680 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1222280 |l FLA01 |p ZDB-4-EBU |q FLA_PDA_EBU |x Aggregator |3 Volltext | |
Record in the Search Index
| _version_ | 1804179192697323520 |
|---|---|
| any_adam_object | |
| author | Kinch, Michael S. |
| author_facet | Kinch, Michael S. |
| author_role | aut |
| author_sort | Kinch, Michael S. |
| author_variant | m s k ms msk |
| building | Verbundindex |
| bvnumber | BV045360089 |
| collection | ZDB-4-EBU |
| contents | The introduction of new medicines has dramatically improved the quantity and quality of individual and public health while contributing trillions of dollars to the global economy. In spite of these past successes -- and indeed because of them -- our ability to deliver new medicines may be quickly coming to an end. Moving from the beginning of the twentieth century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy. To explain how we have arrived at this pivotal moment, Michael Kinch recounts the history of pharmaceutical and biotechnological advances in the twentieth century. Kinch relates stories of the individuals and organizations that built the modern infrastructure that supports the development of innovative new medicines. He shows that an accelerating cycle of acquisition and downsizing is cannibalizing that infrastructure Kinch demonstrates the dismantling of the pharmaceutical and biotechnological research and development enterprises could also provide opportunities to innovate new models that sustain and expand the introduction of newer and better breakthrough medicines in the years to come. - Publisher |
| ctrlnum | (ZDB-4-EBU)ocn959609251 (OCoLC)959609251 (DE-599)BVBBV045360089 |
| dewey-full | 615.1/9 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.1/9 |
| dewey-search | 615.1/9 |
| dewey-sort | 3615.1 19 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03096nmm a2200433zc 4500</leader><controlfield tag="001">BV045360089</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">181212s2016 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1469630648</subfield><subfield code="9">1-4696-3064-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781469630649</subfield><subfield code="9">978-1-4696-3064-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-4-EBU)ocn959609251</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)959609251</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045360089</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.1/9</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kinch, Michael S.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A prescription for change</subfield><subfield code="b">the looming crisis in drug development</subfield><subfield code="c">Michael S. Kinch</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chapel Hill</subfield><subfield code="b">The University of North Carolina Press</subfield><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xi, 339 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Luther H. Hodges, Jr. and Luther H. Hodges, Sr. series on business, entrepreneurship, and public policy</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Print version record</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">The introduction of new medicines has dramatically improved the quantity and quality of individual and public health while contributing trillions of dollars to the global economy. In spite of these past successes -- and indeed because of them -- our ability to deliver new medicines may be quickly coming to an end. Moving from the beginning of the twentieth century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy. To explain how we have arrived at this pivotal moment, Michael Kinch recounts the history of pharmaceutical and biotechnological advances in the twentieth century. Kinch relates stories of the individuals and organizations that built the modern infrastructure that supports the development of innovative new medicines. He shows that an accelerating cycle of acquisition and downsizing is cannibalizing that infrastructure Kinch demonstrates the dismantling of the pharmaceutical and biotechnological research and development enterprises could also provide opportunities to innovate new models that sustain and expand the introduction of newer and better breakthrough medicines in the years to come. - Publisher</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BUSINESS & ECONOMICS / Development / Business Development</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug development</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Research / Economic aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmaceutical industry</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="x">Economic aspects</subfield><subfield code="a">Pharmaceutical industry</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">Kinch, Michael S.</subfield><subfield code="t">Prescription for change</subfield><subfield code="d">Chapel Hill : University of North Carolina Press, [2016]</subfield><subfield code="z">9781469630625</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBU</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030746680</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1222280</subfield><subfield code="l">FLA01</subfield><subfield code="p">ZDB-4-EBU</subfield><subfield code="q">FLA_PDA_EBU</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV045360089 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:15:58Z |
| institution | BVB |
| isbn | 1469630648 9781469630649 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030746680 |
| oclc_num | 959609251 |
| open_access_boolean | |
| physical | 1 online resource (xi, 339 pages) |
| psigel | ZDB-4-EBU ZDB-4-EBU FLA_PDA_EBU |
| publishDate | 2016 |
| publishDateSearch | 2016 |
| publishDateSort | 2016 |
| publisher | The University of North Carolina Press |
| record_format | marc |
| series2 | Luther H. Hodges, Jr. and Luther H. Hodges, Sr. series on business, entrepreneurship, and public policy |
| spelling | Kinch, Michael S. Verfasser aut A prescription for change the looming crisis in drug development Michael S. Kinch Chapel Hill The University of North Carolina Press 2016 1 online resource (xi, 339 pages) txt rdacontent c rdamedia cr rdacarrier Luther H. Hodges, Jr. and Luther H. Hodges, Sr. series on business, entrepreneurship, and public policy Print version record The introduction of new medicines has dramatically improved the quantity and quality of individual and public health while contributing trillions of dollars to the global economy. In spite of these past successes -- and indeed because of them -- our ability to deliver new medicines may be quickly coming to an end. Moving from the beginning of the twentieth century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy. To explain how we have arrived at this pivotal moment, Michael Kinch recounts the history of pharmaceutical and biotechnological advances in the twentieth century. Kinch relates stories of the individuals and organizations that built the modern infrastructure that supports the development of innovative new medicines. He shows that an accelerating cycle of acquisition and downsizing is cannibalizing that infrastructure Kinch demonstrates the dismantling of the pharmaceutical and biotechnological research and development enterprises could also provide opportunities to innovate new models that sustain and expand the introduction of newer and better breakthrough medicines in the years to come. - Publisher MEDICAL / Pharmacology bisacsh BUSINESS & ECONOMICS / Development / Business Development bisacsh Drug development fast Drugs / Research / Economic aspects fast Pharmaceutical industry fast Drug Design Drug development Drugs Research Economic aspects Pharmaceutical industry Erscheint auch als Druck-Ausgabe Kinch, Michael S. Prescription for change Chapel Hill : University of North Carolina Press, [2016] 9781469630625 |
| spellingShingle | Kinch, Michael S. A prescription for change the looming crisis in drug development The introduction of new medicines has dramatically improved the quantity and quality of individual and public health while contributing trillions of dollars to the global economy. In spite of these past successes -- and indeed because of them -- our ability to deliver new medicines may be quickly coming to an end. Moving from the beginning of the twentieth century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy. To explain how we have arrived at this pivotal moment, Michael Kinch recounts the history of pharmaceutical and biotechnological advances in the twentieth century. Kinch relates stories of the individuals and organizations that built the modern infrastructure that supports the development of innovative new medicines. He shows that an accelerating cycle of acquisition and downsizing is cannibalizing that infrastructure Kinch demonstrates the dismantling of the pharmaceutical and biotechnological research and development enterprises could also provide opportunities to innovate new models that sustain and expand the introduction of newer and better breakthrough medicines in the years to come. - Publisher MEDICAL / Pharmacology bisacsh BUSINESS & ECONOMICS / Development / Business Development bisacsh Drug development fast Drugs / Research / Economic aspects fast Pharmaceutical industry fast Drug Design Drug development Drugs Research Economic aspects Pharmaceutical industry |
| title | A prescription for change the looming crisis in drug development |
| title_auth | A prescription for change the looming crisis in drug development |
| title_exact_search | A prescription for change the looming crisis in drug development |
| title_full | A prescription for change the looming crisis in drug development Michael S. Kinch |
| title_fullStr | A prescription for change the looming crisis in drug development Michael S. Kinch |
| title_full_unstemmed | A prescription for change the looming crisis in drug development Michael S. Kinch |
| title_short | A prescription for change |
| title_sort | a prescription for change the looming crisis in drug development |
| title_sub | the looming crisis in drug development |
| topic | MEDICAL / Pharmacology bisacsh BUSINESS & ECONOMICS / Development / Business Development bisacsh Drug development fast Drugs / Research / Economic aspects fast Pharmaceutical industry fast Drug Design Drug development Drugs Research Economic aspects Pharmaceutical industry |
| topic_facet | MEDICAL / Pharmacology BUSINESS & ECONOMICS / Development / Business Development Drug development Drugs / Research / Economic aspects Pharmaceutical industry Drug Design Drug development Drugs Research Economic aspects Pharmaceutical industry |
| work_keys_str_mv | AT kinchmichaels aprescriptionforchangetheloomingcrisisindrugdevelopment |